Clinical Trials Browser

Phase 4 × Early Stage Breast Cancer × Filgrastim × Clear all

NCT02816112 2020-05-27

REaCT-TC2

Phase 4 Completed

Early Stage Breast Cancer

NCT02816164 2019-09-06

REaCT-G2

Phase 4 Completed

Early Stage Breast Cancer